Believe it or not, Michelle Schroeder-Garner is on track to make $1 million this year from traveling and blogging. How is that possible? Your Cheddar host Tim Stenovec explores how digital ads and affiliate marketing helps Schroeder-Garner earn more than $100,000 a month.
Schroeder-Garner publishes her monthly income statements in an attempt to be transparent about her finances. She also says it's a good way to hold yourself accountable throughout the month. It allows you to see when you're spending too much and what you need to adjust. But how does she make $100,000 a month? Schroeder-Garner explains that she endorses about 10 core products and a few outliers on occasion. She also works digital advertising into her blog.
Plus, Schroeder-Garner talks about living a minimalist life. She travels the country in an RV and thinks very thoughtfully about every purchase since space is an issue! She also reveals that she and her husband invest 90% of her take-home pay. Schroeder-Garner reveals the key to passive investing and explains different ways to make extra cash.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
